thujacapital.com
AlpInvest Life Sciences | funds | Thuja Capital
http://thujacapital.com/fund/alpinvest
Thuja Capital Healthcare Fund I. Thuja Capital Healthcare Seed Fund I. Thuja Capital Healthcare Seed Fund II. You are here Thuja Capital. Portfolio AlpInvest Life Sciences. Vernalis - Visit website. Vernalis is a development-stage pharmaceutical company listed on the London Stock Exchange. Omrix - Visit website. Intercell - Visit website. Ingenium - Visit website. Galapagos - Visit website. Epicept - Visit website. EpiCept Corporation is a specialty niche pharmaceutical company. Epicept’s objec...Enanta ...
diabesity.eu
Diabesity - Sixth Framework Programme
http://www.diabesity.eu/members.htm
The DIABESITY project involved 27 partners in 24 European institutions. However the project is now terminated. Final Report and contact details. Göteborg University, Sweden. Prof Sven Enerbäck. Göteborg University, Sweden. Göteborg University, Sweden. Prof Arne Vernon Astrup. The Royal Veterinary and Agricultural University, Denmark. Dr Inês Barroso. Genome Research Limited, UK. Imperial College London, UK. DeveloGen AG, Germany. The University of Cologne, Germany. MRC Mammalian Genetics Unit, UK.
thujacapital.com
Portfolio | Thuja Capital
http://thujacapital.com/portfolio
Thuja Capital Healthcare Fund I. Thuja Capital Healthcare Seed Fund I. Thuja Capital Healthcare Seed Fund II. You are here Thuja Capital. Argenx b.v. - Visit website. Thuja Capital Healthcare Fund I. Argenx is monoclonal antibody company employing proprietory superior therapeutic antibody discovery platform to develop own antibody product portfolio. Avantium B.V. - Visit website. Bioceros B.V. - Visit website. Thuja Capital Healthcare Fund I. BioXell - Visit website. Breonics - Visit website. Thuja Capit...
projectnet.diabesity.eu
Diabesity - Sixth Framework Programme
http://projectnet.diabesity.eu/members.htm
The DIABESITY project involved 27 partners in 24 European institutions. However the project is now terminated. Final Report and contact details. Göteborg University, Sweden. Prof Sven Enerbäck. Göteborg University, Sweden. Göteborg University, Sweden. Prof Arne Vernon Astrup. The Royal Veterinary and Agricultural University, Denmark. Dr Inês Barroso. Genome Research Limited, UK. Imperial College London, UK. DeveloGen AG, Germany. The University of Cologne, Germany. MRC Mammalian Genetics Unit, UK.
diabposition.blogspot.com
Diabetes: March 2011
http://diabposition.blogspot.com/2011_03_01_archive.html
DIABETES CIES SEARCH ENGINE [SELECTED WEBSITES]. Mylan Pharmaceuticals : Approval for Generic Versi. Biocrates Life Sciences : Metabolomic biomarker . NeuroMetrix Announces New Strategic Direction : Pr. Sanofi-aventis Acquires from Ascendis Pharma World. Evotec : Metabolic disease alliance with MedImmun. Tuesday, March 29, 2011. Mylan Pharmaceuticals : Approval for Generic Version of Precose Tablets. Jan 18, 2011 - Mylan Inc. (Nasdaq: MYL). Announced that its subsidiary Mylan Pharmaceuticals Inc. Current...